Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Aetiology of congenital heart disease explained

08.02.2005


Researchers at Karolinska Institutet have identified the mechanisms behind the serious, congenital heart condition that can sometimes develop in children of women with a rheumatic disease.



This serious form of congenital heart disease, known as AV heart block, develops when a certain type of antibody is transferred from the mother to the foetus during pregnancy. The antibodies are targeted against endogenous proteins and cause the inflammation and calcification of the foetal cardiac conduction system. One in three of such cases are fatal to the foetus, and approximately 70 per cent of the babies born alive require life-long pacemaker treatment.

The mothers normally have a rheumatic disease, such as Sjögren’s syndrome or SLE. In virtually all cases of congenital heart block, the mother produces antibodies against the Ro and La autoantigens, but in only 2-5 per cent of pregnancies amongst Ro and La positive women does this heart condition arise.


This study has identified the specific antibody that causes the damage, and explained its mechanism of action. The antibody targets a specific part of the Ro protein known as p200. The study shows that the level of p200 antibodies in the mother correlates with the degree of damage to the heart. The results have been further confirmed in studies on rats and in cell cultures. Cultivated heart cells, cardiomyocytes, were seriously affected in their calcium balance when exposed to specific p200 antibodies. The cells were rendered unable to accumulate calcium, which ultimately led to cell death, apoptosis.

Knowledge of how this congenital heart condition arises will go a long way towards helping scientists develop better screening, risk assessment and treatment techniques. This is particularly important as early intervention has proved to restrict the extent of the damage, thus preventing pacemaker dependence or foetal death.

“We believe that the antibody we’ve identified can be used as a marker for identifying the mothers who are at a high risk of developing this complication during pregnancy,” says associate professor Marie Wahren-Herlenius. “We’re now working together with Karolinska University Hospital on designing a suitable method for this.”

Tina Zethraeus | alfa
Further information:
http://www.vr.se

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>